Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
As of Apr. 2026, Calamos L/S Equity & Dynamic Trust has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Apr. 2026, Calamos L/S Equity & Dynamic Trust has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
Calamos L/S Equity & Dynamic Trust Sloan Ratio % Related Terms
Calamos L/S Equity & Dynamic Trust Sloan Ratio % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Calamos L/S Equity & Dynamic Trust Sloan Ratio % Chart
For the Asset Management subindustry, Calamos L/S Equity & Dynamic Trust's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Calamos L/S Equity & Dynamic Trust Sloan Ratio % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Calamos L/S Equity & Dynamic Trust's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Calamos L/S Equity & Dynamic Trust's Sloan Ratio % falls into.
Calamos L/S Equity & Dynamic Trust Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Calamos L/S Equity & Dynamic Trust (CPZ) has a Sloan Ratio % of 0.00% as of Apr. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Calamos L/S Equity & Dynamic Trust and its competitors.
Is Calamos L/S Equity & Dynamic Trust's Sloan Ratio % too high?
Calamos L/S Equity & Dynamic Trust's current Sloan Ratio % is 0.00%. Overall, Calamos L/S Equity & Dynamic Trust has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Calamos L/S Equity & Dynamic Trust's Sloan Ratio % compare to NHS and JRS?
Calamos L/S Equity & Dynamic Trust's Sloan Ratio % of 0.00% can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for an Asset Management company?
A good Sloan Ratio % depends on the Asset Management industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Calamos L/S Equity & Dynamic Trust and its competitors. Calamos L/S Equity & Dynamic Trust's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Calamos L/S Equity & Dynamic Trust stock overvalued right now?
Based on GuruFocus' analysis, Calamos L/S Equity & Dynamic Trust (CPZ) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.41, compared to a current price of $13.36 — trading 847.5% above its estimated fair value. The current Sloan Ratio % is 0.00%. Calamos L/S Equity & Dynamic Trust's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Calamos L/S Equity & Dynamic Trust (CPZ), the current Sloan Ratio % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Calamos L/S Equity & Dynamic Trust (CPZ) Overvalued in 2026?
Based on GuruFocus' analysis, Calamos L/S Equity & Dynamic Trust stock appears to be overvalued.
The current stock price of $13.36 is trading 847.5% above its estimated GF Value™ of $1.41.
GuruFocus considers Calamos L/S Equity & Dynamic Trust to be Significantly Overvalued.
Key valuation signals for CPZ:
Sloan Ratio %: 0.00%
GF Value™: $1.41 vs. price of $13.36 (847.5% above fair value)
No single metric tells the full story. See the CPZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Calamos L/S Equity & Dynamic Inc Trust is a trust company that seeks to provide current income and risk-managed capital appreciation, with an investment objective to deliver total return through a combination of capital appreciation and current income. The Fund invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary, and others, and holds securities with a broad range of maturities, with the average term to maturity typically ranging from two to ten years. Managed assets represent the Fund's total assets, including any assets attributable to leverage that may be outstanding, minus total liabilities other than debt representing financial leverage.
32GF Score
Get the complete analysis for CPZ
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CPZ has been successfully added to your 
